Drug Topics
AUGUST 31, 2022
Drug Topics® is joined by Joseph Mann, MSN, FNP-C, to discuss pharmacy’s fast-expanding role in COVID care, variant BA.5’s diagnostic impact, and the benefits of different tests available — including how technology behind a smartphone-integrated home test creates a fluid experience for patients.
PharmaVoice
AUGUST 17, 2022
Recent data from Vaxart’s phase 1 trial of its COVID-19 inoculation pill shows potential.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PhRMA
AUGUST 29, 2022
We are committed to engaging a wide range of audiences and having a dialogue on opportunities to create a better health care system. We believe health literacy can not only help patients make appropriate decisions about their own health but also help enable constructive conversations on how we can support a regulatory and policy environment that helps patients access life-saving medications.
Pharmacy Times
AUGUST 18, 2022
Analysis is based on functional magnetic resonance imaging to provide insight into the effective connectivity.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
AUGUST 12, 2022
Half a million people in the UK with conditions like blood cancer that prevents them being protected from COVID-19 vaccines are facing another winter shielding, because the government has shelved plans to offer treatment with AstraZeneca’s antibody therapy Evusheld. That’s the position of multiple patient organisations, clinicians and medical groups, who have criticised the Department of Health’s decision to defer procurement of Evusheld supplies until cost-effectiveness agency
European Pharmaceutical Review
AUGUST 25, 2022
Following numerous recalls, the industry is striving to investigate the causes, sources and ways to mitigate carcinogenic nitrosamine impurities. In a recent paper, published in the International Journal of Pharmaceutics , researchers identified nitrocellulose blister packaging as a potential source of N -nitrosodimethylamine (NDMA) and N -nitrosodiethylamine (NDEA) impurities.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
PharmaVoice
AUGUST 30, 2022
The Community Alliance Network is the latest industry initiative looking to the pharmacy counter to help improve trial recruitment diversity.
PhRMA
AUGUST 16, 2022
Innovative biopharmaceutical research companies have been dedicated to fighting COVID-19 for over two years. Since the start of the pandemic, America’s biopharmaceutical companies have worked around the clock to research, develop and manufacture treatments and vaccines to fight COVID-19. We’ve made unprecedented progress in a short time thanks to decades of experience having produced over 14 billion vaccines globally to date.
Pharmacy Times
AUGUST 24, 2022
Analysis includes nearly 43 million individuals aged 13 year and older who received at least 1 dose in England between December 1, 2020, and December 15, 2021.
pharmaphorum
AUGUST 8, 2022
A study of a mobile health app used to support patients hospitalised with heart failure has concluded that it provided a modest improvement in quality-of-life scores, as well as better clinical outcomes. The finding comes from the large-scale CONNECT-HF cluster study, which looked at various patient engagement and education interventions to see if they could help patients with heart failure do better after discharge from hospital.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
AUGUST 12, 2022
In June this year, it was announced that the US Food and Drug Administration (FDA) had granted UK-based OxfordVR a breakthrough device designation for its gameChangeVR treatment to deliver immersive cognitive behaviour therapy (CBT) to people suffering from schizophrenia and other mental illnesses. The FDA’s breakthrough device programme is for medical devices or device-led combination products that provide more effective treatment or diagnosis of diseases.
Drug Topics
AUGUST 29, 2022
New research looks at the potential benefits of long-term statin use in patients who are at increased risk of cardiovascular disease.
PharmaVoice
AUGUST 10, 2022
Miruna Sasu is on a mission to use real world data to help wipe out cancer. She believes this audacious goal is within reach, and as president and CEO of COTA, she is inspiring her team to create a “path to care” for oncology patients.
PhRMA
AUGUST 10, 2022
Last weekend, the Senate passed the Inflation Reduction Act which includes dangerous price-setting provisions. The bill now heads to the House for consideration, where it is not too late for them to stand up for patients and medical innovation by opposing the bill.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
AUGUST 23, 2022
Francesca Ceddia, MD, senior vice president of respiratory vaccines at Moderna, said the company is in early stages of development for a combined mRNA vaccine for influenza, COVID-19, and RSV.
pharmaphorum
AUGUST 23, 2022
With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the case with the creation of a treatment for Long COVID. The condition is more common than might be thought and presents a significant burden to patients, and yet the pipeline of potential therapies remains relatively sparse. When the pandemic first struck, the gravity of the situation did not take long to set in.
IDStewardship
AUGUST 29, 2022
In this short special interest piece, an infectious disease pharmacists who went viral with one of his social media posts is interviewed. Interview with: Michael Bosco, Pharm.D., BCIDP, AAHIVP. Interview by: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 29 August 2022. A few years ago we posted an article about someone who is pharmacy famous.
Drug Topics
AUGUST 26, 2022
Medicare users will see prescription drug pricing reform thanks to the Inflation Reduction Act.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmaVoice
AUGUST 22, 2022
A look at how the biggest pharma companies in the world and their top-selling drugs fared in the first half of the year.
PhRMA
AUGUST 3, 2022
As members of Congress continue to push forward misguided government price-setting policies under the guise of “negotiation,” patient advocates across the country have been speaking out in local media outlets about the potential consequences.
Pharmacy Times
AUGUST 8, 2022
Investigators found that the health risks linked to the condition known as metabolic syndrome could be diminished by green tea’s anti-inflammatory benefits in the gut.
Pharmacy Is Right For Me
AUGUST 10, 2022
There are so many different types of careers within the field of pharmacy—from research and drug development to pharmacy informatics! To highlight some of the more unique career settings in the industry, we’re introducing a new page on our website— Novel Pharmacy Practice Settings —where you can explore these unique career pathways. In addition to learning more about unique pathways on our new webpage, we’ll also be featuring pharmacists who work in these unique settings on our blog.
IDStewardship
AUGUST 27, 2022
In this article a pharmacist with experience in didactic and experiential education discusses top five reasons pharmacy preceptors fail. . Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 28 August 2022. Sometimes the best way to learn is to fail. I have learned a lot, as I have failed my fair share of times while serving as a pharmacy student preceptor, PGY-1 pharmacy resident preceptor, PGY-2 pharmacy resident preceptor, medical fellow preceptor, and pharmacy residency
Drug Topics
AUGUST 25, 2022
Researchers report that half of the online pharmacies are rogue operations that may operate without a license or have other serious shortcomings.
PharmaVoice
AUGUST 29, 2022
The biosimilar developer is advancing a pipeline with high growth potential, including a copycat of Humira.
PhRMA
AUGUST 8, 2022
Despite having insurance, too many patients with HIV face high out-of-pocket costs for brand medicines. This is largely driven by insurer-imposed barriers that shift the cost of life-saving care onto patients.
Pharmacy Times
AUGUST 25, 2022
As pharmacists take on new responsibilities, researchers have been studying the effects of pharmacists on interprofessional care teams.
European Pharmaceutical Review
AUGUST 26, 2022
Scientists from the Gladstone Institutes and University of California San Francisco (UCSF) say a new variation of the CRISPR-Cas9 gene editing system enables especially long DNA sequences to be introduced to precise locations in the genomes of cells with remarkably high efficiency without the need for viral vectors. “One of our goals for many years has been to put lengthy DNA instructions into a targeted site in the genome in a way that doesn’t depend on viral vectors,” commented Alex Marson, MD
IDStewardship
AUGUST 20, 2022
In this article a list of medication names for dogs and other animals is provided. Composed By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 20 August 2022. Recently @HaPhanPharmD asked the twitterverse for good medication names for dogs. Many people commented, sharing some actual names of their pets (see below) or hypothetical names that would be a possible name for a dog (or pair of dogs).
Drug Topics
AUGUST 30, 2022
More women are using medical cannabis for menopause-related symptoms.
PharmaVoice
AUGUST 30, 2022
The biotech says that its competitors’ COVID-19 vaccine copied proprietary mRNA technology. Here’s a breakdown of the case.
PhRMA
AUGUST 12, 2022
With a final vote in Congress expected on a reconciliation spending bill, a new Morning Consult survey explores what this legislation actually does – and does not do – and finds that voters are skeptical of its impact on inflation, worried about the consequences of Medicare “negotiation” and concerned the bill doesn’t do enough to help make medicines affordable for patients.
Pharmacy Times
AUGUST 29, 2022
New research indicates that COVID-19 vaccinations did not increase the risks of preterm births or gestational issues for pregnant women, despite prior conflicting evidence.
Expert insights. Personalized for you.
469 
Let's personalize your content